BioSapien Inc.
Let's Change Treatment
San Diego, United States · Founded 2018 · $21.4M raised
- Headquarters
- San Diego, California
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- biosapien.com
- Total Funding
- $21.4M
- Last Round
- $2.5M Pre-SeedJan 2025
- Rounds
- 6
About
BioSapien is a San Diego-based late-stage preclinical company developing minimally invasive drug delivery platforms for cancer treatment. Its flagship MediChip® technology uses 3D printing to deliver targeted chemotherapy directly to solid tumors, minimizing systemic side effects.
Summary
BioSapien Inc. is a Biotech company based in San Diego, United States, founded in 2018. It has raised $21.4M in total across 6 rounds, most recently a $2.5M Pre-Seed round in Jan 2025. Investors include SOSV, Hikma Ventures and Globivest.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company